Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
The University of Southampton is seeking to make the appointment to the role of Senior CAFM Manager. The University of Southampton is a leading research-intensive University, a founding member of the prestigious Russell Group, and one of the top 100 universities worldwide. We deliver excellent...
-
An exciting opportunity is available for a talented researcher to join a successful team within the Primary Care Research Centre to support the process evaluation and implementation of a digital e
-
process evaluation and implementation of a digital e-health intervention for young people with acne (Acne Care Online ). The post is available under the supervision of Professor Miriam Santer and Dr Rosie
-
the MRC uses a multidisciplinary approach of mass spectrometry, microscopy, and cell-based assays to explore how dysfunctional carbohydrate-processing causes disease. The post offers huge potential in
-
The School of Health Sciences, University of Southampton, invites applications for an exciting research position within the Extreme Temperature and Health OutcomeS (ETHOS) project. This Natural
-
report to the Chief Investigator of the PRANA research programme. Duties and Key Responsibilities Utilise Python / SQL / Languages to create automated data flow pipelines from multiple sources into a
-
We are seeking to appoint a research technician to the NK cell team within The School of Clinical and Experimental Sciences. This exciting project will assess how we can enhance natural killer (NK
-
experiments (e.g. native/Hdx-MS, SPR or FRET). Qualifications: Proficiency in at least one computer language as in C++ and/or Python is required. This project also uses Javascript, REACT, and GTK. Experience in
-
, and nature based solutions, across regional, national and international scales We strongly encourage applicants from groups traditionally under-represented in the UK higher education sector (you can
-
leukaemia (AML). This three-year project will harness cytotoxic invariant Natural Killer T (iNKT) cells for precision targeting of AML, an aggressive leukaemia with poor survival outcomes. Building on strong